Last update 16 Nov 2025

Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.

Subsidiary Company|1989|Shanghai Shi, China|
100-250

Overview

Tags

Skin and Musculoskeletal Diseases
Other Diseases
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug4
Top 5 TargetCount
AHR(Aryl hydrocarbon receptor)1
Opioid receptors1
β-adrenoceptors(Beta adrenergic receptors)1

Related

4
Drugs associated with Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.
Benvitimod
Target
AHR
Mechanism
AHR agonists
Active Org.
Shanghai Thederma Pharmaceuticals Co., Ltd. [+6]
Originator Org.
Guangdong Zhonghao Pharmaceutical Co. Ltd.Guangdong Zhonghao Pharmaceutical Co. Ltd.
Active Indication
Dermatitis, Atopic [+8]
Inactive Indication
Chronic large plaque psoriasis [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
China
First Approval Date29 May 2019
Timolol Maleate
Target
β-adrenoceptors
Mechanism
β-adrenoceptors antagonists
Active Org.
Central Pharmaceutical JSC No. 3 [+8]
Originator Org.
Bausch Health Americas, Inc.
Active Indication
Hemangioma [+4]
Inactive Indication
Capillary Hemangioma [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date17 Aug 1978
Loperamide Hydrochloride
Target
Opioid receptors
Mechanism
Opioid receptors agonists
Active Org.
Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd. [+3]
Originator Org.
Johnson & JohnsonJohnson & Johnson
Active Indication
Acute diarrhea [+1]
Inactive Indication
Eye Pain [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date28 Dec 1976
14
Clinical Trials associated with Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.
CTR20251433
/ RecruitingPhase 3
评价TAP-1503乳膏在3-24月龄特应性皮炎患者中的安全性、有效性和药代动力学的单臂、开放标签的临床试验
[Translation] A single-arm, open-label clinical trial to evaluate the safety, efficacy, and pharmacokinetics of TAP-1503 cream in patients aged 3-24 months with atopic dermatitis
CTR20250227
/ CompletedNot Applicable
单硝酸异山梨酯缓释片在中国健康受试者中单中心、开放、随机、单剂量、双周期、双交叉空腹及餐后状态下的生物等效性试验
[Translation] A single-center, open-label, randomized, single-dose, two-period, double-crossover bioequivalence study of isosorbide mononitrate extended-release tablets in Chinese healthy subjects under fasting and fed conditions
CTR20241337
/ RecruitingPhase 2
评估乙酸避孕凝胶在健康成年女性受试者中避孕效果及安全性的多中心、随机、盲法、阳性药平行对照的Ⅱ期临床研究
[Translation] A multicenter, randomized, blinded, active-drug parallel-controlled phase II clinical study to evaluate the contraceptive efficacy and safety of acetic acid contraceptive gel in healthy adult female subjects
100 Clinical Results associated with Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.
Login to view more data
100 Deals associated with Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
1
Phase 3
NDA/BLA
1
1
Approved
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Loperamide Hydrochloride
 ( Opioid receptors )		Diarrhea
More
Approved
Timolol Maleate
 ( β-adrenoceptors )		Hemangioma
More
NDA/BLA
Benvitimod
 ( AHR )		Moderate Atopic Dermatitis
More
Phase 3
Acetic Acid, Glacial
Contraception
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free